PharmaGard NU-PR797-400 Compounding Aseptic Isolator USNS Comfort
Closed Pre-Solicitation Posted
- Solicitation number
- N0018926XXXXX
- Agency
-
Naval Supply Systems Command
Department of the Navy, Department of Defense
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- Norfolk, Virginia 23511, United States
- Points of contact
Notice details come from SAM.gov. Updated .
About this opportunity
Naval Supply Systems Command intends to conduct a sole-source acquisition of a PharmaGard NU-PR797-400 Compounding Aseptic Isolator manufactured by NuAire, Inc., with a response deadline of 19 September 2026. This procurement is justified as sole source under FAR 12.102(a) because the unit is the only authorized equipment approved for pharmacy spaces aboard Navy hospital ships (USNS Comfort and USNS Mercy) and is standardized across the platform.
The isolator is a sealed, glove-box design with HEPA-filtered laminar airflow certified to ISO Class 5 positive-pressure pharmaceutical compounding environments and USP 797 standards. It serves as a primary engineering control for sterile compounding in support of disaster relief, humanitarian assistance, and major combat operations aboard the USNS Comfort. The required delivery date is 15 September 2026 in support of the Continuing Promise 2026 mission in the Southern Command Area of Responsibility.
The sole-source justification cites standardization requirements, space mounting constraints, fitment compatibility with existing systems, alignment with AMAL 6234 pharmacy equipment standards, and the fact that current units are beyond their life expectancy. NuAire, Inc. holds CAGE Code 58194. The Government will process this procurement under FAR Part 12 procedures as a firm fixed-price purchase order. The applicable NAICS code is 334516 (Analytical Laboratory Instrument Manufacturing) with a business size standard of 1,000 employees. The Government reserves the right to proceed with sole-source award or open the procurement to competition based on responses received.
Notice text
The requirement is to acquire the PharmaGard NU-PR797-400 Compounding Aseptic Isolator, a CAI manufactured by vendor Nuaire in support of pharmacy operations onboard the USNS Comfort. The isolator will ensure sterile compounding capabilities for optimized patient care in isolated regions around the globe; supporting disaster relief, humanitarian assistance, and major combat operations. This unit has been standardized across the hospital ships platform within the Navy.
Files
| File | Type | Posted |
|---|---|---|
| SSJ PharmaGard - Comfort_Redacted.pdf | ||
| Synopsis.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| This notice | Pre-Solicitation | |
| NMFDC Emergency Nurse Residency Program | Pre-Solicitation |
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| Notice of intent to award a sole source | Naval Supply Systems Command | No set-aside | |
| Preventative Maintenance and FullCare Service Support for Cytiva Sepax C-PRO Cell Separation Systems | Office of Logisitics and Acquisition Operations | No set-aside | |
| System assembly, sub | Naval Supply Systems Command | No set-aside | |
| Compressor unit, REC | Naval Supply Systems Command | No set-aside | |
| Comprehensive full-service maintenance/repair plan for Illumina Nova/Seq 6000 | Naval Supply Systems Command | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity